Cutaneous melanoma
- 1 March 2014
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 383 (9919), 816-827
- https://doi.org/10.1016/s0140-6736(13)60802-8
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- KIT as a Therapeutic Target in Metastatic MelanomaJama-Journal Of The American Medical Association, 2011
- A phase 2 trial of complete resection for stage IV melanomaCancer, 2011
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- Sunbed use during adolescence and early adulthood is associated with increased risk of early‐onset melanomaInternational Journal of Cancer, 2010
- Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use settingCancer, 2010
- CTLA-4 Blockade Confers Lymphocyte Resistance to Regulatory T-Cells in Advanced Melanoma: Surrogate Marker of Efficacy of Tremelimumab?Clinical Cancer Research, 2008
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990sEuropean Journal Of Cancer, 2008
- MC1R variants, melanoma and red hair color phenotype: A meta‐analysisInternational Journal of Cancer, 2008